People living with the chronic heart condition ATTR-CM can experience emotional health challenges such as anxiety and ...

A demographic shift toward an aging population is occurring worldwide. Commensurate with this trend, age-related diseases are also rising. Although aging is an immutable part of life, biological aging ...

Cardiovascular biotech Tenaya Therapeutics has signed a research collaboration agreement with RNAi specialist Alnylam Pharmaceuticals, in a deal that includes a $10 million upfront payment and much ...

Life expectancy for people with ATTR amyloidosis varies, generally ranging from 3 to 15 years after symptoms appear, and depends on the specific type of the condition and any other health issues a ...

Caring for someone with ATTR amyloidosis can be physically and emotionally demanding. To reduce the chances of burnout, caregivers should also prioritize their own well-being. Factors such as ...

ABSTRACT: Transthyretin cardiac amyloidosis is an important cause of chronic heart failure with preserved ejection fraction in the adult population; however, it remains underdiagnosed due to a lack of ...

Managing Afib: Is There a Difference in HFpEF vs HFrEF Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular ...

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy Receive the the latest news, ...

The MarketWatch News Department was not involved in the creation of this content. MISSISSAUGA, ON, March 2, 2026 /CNW/ - Alnylam Canada ULC is pleased to announce it has received a positive ...

Intellia Therapeutics' shares were set for a strong open Monday after the Food and Drug Administration lifted the clinical hold on the investigational new drug application for biopharmaceutical ...

"This recommendation brings us one step closer to delivering access to a first‑in‑class treatment that has a fundamentally different mechanism of action, targeting the root cause of the disease, ...

ATTR-CM, a stiffening of the heart that affects pumping blood, is diagnosed through tests like EKGs and MRIs. Genetic testing can help identify if ATTR-CM is hereditary or wild-type. Nuclear ...